奈良宣言（ALT over 30）のMASLD（metabolic dysfunction-associated steatotic liver disease）における臨床的意義の検証
M. Kawanaka, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, H. Toyoda, S. Oeda, H. Hyogo, A. Morishita, K. Munekage, K. Kawata, Tsubasa Tsutsumi, Koji Sawada, T. Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, A. Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, S. Yasuda, Eiichi Tomita, M. Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima
{"title":"奈良宣言（ALT over 30）のMASLD（metabolic dysfunction-associated steatotic liver disease）における臨床的意義の検証","authors":"M. Kawanaka, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, H. Toyoda, S. Oeda, H. Hyogo, A. Morishita, K. Munekage, K. Kawata, Tsubasa Tsutsumi, Koji Sawada, T. Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, A. Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, S. Yasuda, Eiichi Tomita, M. Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima","doi":"10.2957/kanzo.65.186","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17925,"journal":{"name":"Kanzo","volume":"760 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kanzo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.65.186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
评估奈良宣言（ALT 超过 30）在 MASLD（代谢功能障碍相关性脂肪肝）中的临床意义。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
